WASHINGTON — Trump administration officers are anticipated to launch extra particulars on their plan to decrease prescription drug costs within the coming days and have been assembly with pharmaceutical business leaders in regards to the potential impacts.
The drug corporations, in flip, have been gaming out attainable eventualities — and strategizing how they might reply to the White Home, 5 individuals concerned within the planning stated.
Administration officers introduced on Might 12 a brand new coverage that sought to decrease U.S. drug costs to place them in keeping with what different nations pay, a so-called most-favored nation plan. President Trump signed an govt order that day requiring well being secretary Robert F. Kennedy Jr. to set value objectives inside 30 days, setting the stage for negotiations between the drug corporations and the administration.
This text is unique to STAT+ subscribers
Unlock this text — plus every day intelligence on Capitol Hill and the life sciences business — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
